Relapsed/Refractory Secondary Central Nervous System Lymphoma
1 clinical trials · Condition
◉ Watch Relapsed/Refractory Secondary Central Nervous System Lymphoma
| Record | Firm | Date |
|---|---|---|
| Autologous CD19-CD20-NKG2D-nsBicephali CAR-T for Relapsed/Refractory Central Nervous System Lymphoma (NCT07555561) | Beijing Boren Hospital | 2026-09-01 |
Track Relapsed/Refractory Secondary Central Nervous System Lymphoma automatically
Every clearance here is in the API, with alerts when new ones post.